JONES DAY PRESENTS® The Impact of Digital Health on Research and Clinical Trials
As artificial intelligence (AI) becomes central to financial crime compliance -- powering fraud detection, transaction monitoring, and sanctions screening -- internal audit faces a new challenge: How do you provide assurance...more
The Food and Drug Administration’s (FDA) recent rejection of all study data from Mid-Link Testing highlights the importance of using reliable, valid data for medical device premarket submissions. Our FDA/Food, Drug & Device...more
On January 6, 2025, the FDA released draft guidance on using artificial intelligence (AI) in regulatory decision-making for drugs and biological products. The draft guidance – the first of its kind from the agency – aims to...more